← Evidence map

ArticleTranslational oncology2026

Synergistic effects through targeting the PI3K and IGFR pathways in treating lung cancer carrying activation alterations along the PI3K pathway.

Mohamed Abd El-Salam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Synergistic effects through targeting the PI3K and IGFR pathways in treating lung cancer carrying activation alterations along the PI3K pathway. | OpenQuestion